The next generation of groundbreaking weight loss drugs used by millions is just over the horizon - and they won't require ...

Let's look at why this news could be a game-changer for Eli Lilly and its stock.

Amy Schumer has shared an update on her weight loss journey after speaking out the side effects she experienced using Ozempic ...

China’s response to new United States (U.S.) tariffs could complicate the supply of important medicines, an analysis of data ...

Discover the effectiveness and safety of Mounjaro, the new weight loss drug launched in India. Learn from expert Dr. Pal ...

The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight-loss drugs Ozempic and ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

As CMS maintains limits on GLP-1 coverage for weight loss, new efficacy data and shifting prescribing patterns point to sustained high demand across the drug class. Here are four updates: 1. Federal ...